Thrombopoietin Completed Phase 4 Trials for Aplastic Anemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03896971Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia